ReachMD
CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Visita il sito del podcast e sostieni chi lo crea: reachmd.com
Dove ascoltare?
I podcast nell'app Replaio Radio In arrivoI podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast
Episodi
Switching Strategies: Switch or Stay—What’s Your Call? 31.12.2025 5:45
Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....
Remission: Can You Prove It? 31.12.2025 6:15
Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...
Treat-to-Target: Are We There Yet? 31.12.2025 5:15
Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...
Case Review: Can You Crack This IBD Case? 31.12.2025 6:30
Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...
Tailoring Treatment: Can You Select the Best Therapy? 31.12.2025 6:45
Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....
IBD Immunopathogenesis: Do You Know What You're Blocking? 31.12.2025 7:00
Faculty: Kimberly D. Orleck, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic...
Severity Assessment: Can You Pin the Stage on the Patient? 31.12.2025 6:15
Faculty: Jennifer Geremia, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic t...
Diagnosing IBD: Is It IBD or Something Else? Can You Tell? 31.12.2025 6:00
Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients 31.12.2025 14:45
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Diana Castro and Jonathan Strober discuss treatment strategies for generalized myasthenia gravis (gMG), focusing on pediatric and adolescent care. They review traditional therapies and newer agents, such as FcRn and complement inhibitors, highlighting the role of antibody status and considerations for thymectomy. The conversation also ad...
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens 31.12.2025 14:00
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD This discussion between Drs. Diana Castro and Jonathan Strober focuses on the clinical utility of patient stratification and antibody profiling in generalized myasthenia gravis (gMG). The conversation addresses how age of onset, antibody status (acetylcholine receptor, MuSK, LRP4), and comorbidities can influence diagnosis and management plan...
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages 31.12.2025 11:30
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement,...
Case Review: Targets Are Met—Can You Stick the Landing? 31.12.2025 7:15
Faculty: David Rubin, MD Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. The...
Switching Strategies: Switch or Stay—What’s Your Call? 31.12.2025 5:45
Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....
Remission: Can You Prove It? 31.12.2025 6:15
Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...
Treat-to-Target: Are We There Yet? 31.12.2025 5:15
Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...
Case Review: Can You Crack This IBD Case? 31.12.2025 6:30
Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...
Tailoring Treatment: Can You Select the Best Therapy? 31.12.2025 6:45
Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....
IBD Immunopathogenesis: Do You Know What You're Blocking? 31.12.2025 7:00
Faculty: Kimberly D. Orleck, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic...
Severity Assessment: Can You Pin the Stage on the Patient? 31.12.2025 6:15
Faculty: Jennifer Geremia, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic t...
Diagnosing IBD: Is It IBD or Something Else? Can You Tell? 31.12.2025 6:00
Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients 31.12.2025 14:45
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Diana Castro and Jonathan Strober discuss treatment strategies for generalized myasthenia gravis (gMG), focusing on pediatric and adolescent care. They review traditional therapies and newer agents, such as FcRn and complement inhibitors, highlighting the role of antibody status and considerations for thymectomy. The conversation also ad...
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens 31.12.2025 14:00
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD This discussion between Drs. Diana Castro and Jonathan Strober focuses on the clinical utility of patient stratification and antibody profiling in generalized myasthenia gravis (gMG). The conversation addresses how age of onset, antibody status (acetylcholine receptor, MuSK, LRP4), and comorbidities can influence diagnosis and management plan...
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages 31.12.2025 11:30
Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement,...
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE 30.12.2025 16:15
Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE 30.12.2025 16:15
Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...
Podcast simili
Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici